[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/pages/docs/Benef/index.md) >> Individual ID:PBN__Benef_317 

# __Reduction of infections__

## Articles mentionning this Benefit

* [Applications of ultraviolet germicidal irradiation disinfection in health care facilities: Effective adjunct, but not stand-alone technology](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_103.md)
* [The effect of large-scale anti-contagion policies on the COVID-19 pandemic](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_61.md)

## Category to which it belongs

* [Effective control and elimination of infectious pathogens to prevent disease transmission and reduce the overall risk of infection.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_1.md)

## Description of actual returns pertaining to this benefit

* [Private investors investing in these policies can benefit from a reduction in healthcare costs, a more stable workforce, and improved well-being of the population, leading to better economic conditions.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_334.md)
* [Reduced risk of surgical site infections](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_549.md)

## Name of the Benefit

UVGI reduces levels of airborne bacteria

## Risks which can benefit from this action

* [Direct uvgi](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_516.md)
* [Implementation of anti-contagion policies](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_316.md)

## Stakeholders benefitting from this Benefit

* [General population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_9.md)
* [Medical staff](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_93.md)

